Skip to main content
Medical information Clinical review pending

Genetic Testing

RAPSN Gene Fetal Akinesia Deformation Sequence Genetic Test

Genetic test analyzing the RAPSN gene to identify mutations associated with Fetal Akinesia Deformation Sequence. Provides insights for families and guides clinical decisions.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or Chorionic Villus Sampling (CVS) / Amniotic Fluid (AF) sample. Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required for a blood draw. For CVS or AF samples, follow the instructions provided by your physician.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the RAPSN Gene Fetal Akinesia Deformation Sequence Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Pregnancy with observed reduced fetal movement.
  • ✓Family history of neuromuscular disorders.
  • ✓Previous child affected by Fetal Akinesia Deformation Sequence.
  • ✓Seeking genetic counseling for reproductive planning.
  • ✓Confirmation of suspected FADS diagnosis.
02

In plain language

What this test helps you understand

This test helps identify genetic mutations in the RAPSN gene associated with Fetal Akinesia Deformation Sequence, aiding in diagnosis and genetic counseling.
The RAPSN Gene Fetal Akinesia Deformation Sequence NGS Genetic DNA Test is a specialized genetic test used to help diagnose and understand Fetal Akinesia Deformation Sequence (FADS). FADS is a condition characterized by significantly reduced fetal movement in the womb, which can lead to various physical deformities and developmental challenges. This test utilizes Next Generation Sequencing (NGS) technology to provide detailed information about the RAPSN gene. The RAPSN gene plays a crucial role in the proper functioning of the neuromuscular system. This test specifically looks for mutations or variations within the RAPSN gene that may be linked to FADS. Early detection of potential genetic factors can be important for managing pregnancy and planning for the health of the baby and family.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required for a blood draw. For CVS or AF samples, follow the instructions provided by your physician.
SampleBlood sample (EDTA tube) or Chorionic Villus Sampling (CVS) / Amniotic Fluid (AF) sample. Confirm with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) analysis of the RAPSN gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the RAPSN gene. It may not detect all possible mutations. Results should be interpreted in the context of clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

FADS is a condition where a fetus has very limited movement in the womb, often leading to physical deformities and developmental issues.
The RAPSN gene provides instructions for making a protein important for the proper function of muscles and nerves.
This test may be recommended for pregnant individuals with reduced fetal movement, a family history of neuromuscular disorders, or previous experience with FADS.
Results should be discussed with a healthcare provider or genetic counselor to understand their meaning and implications for your health and family.
Turnaround time varies. Please confirm the current estimated turnaround time with the laboratory before booking.
A blood sample is typically used. In some cases, samples from amniotic fluid or chorionic villus sampling may be used. Confirm the required sample type with the laboratory.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp